Skip to main content
Aadi Bioscience, Inc. (AADI)
NASDAQ: AADI · Real-Time Price · USD
1.805
+0.035 (1.98%)
Sep 13, 2024, 11:53 AM EDT - Market open

Aadi Bioscience Revenue

Aadi Bioscience had revenue of $6.18M in the quarter ending June 30, 2024, a decrease of -0.37%. This brings the company's revenue in the last twelve months to $23.82M, up 10.57% year-over-year. In the year 2023, Aadi Bioscience had annual revenue of $24.35M with 60.06% growth.

Revenue (ttm)
$23.82M
Revenue Growth
+10.57%
P/S Ratio
2.00
Revenue / Employee
$267,607
Employees
89
Market Cap
44.43M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202324.35M9.14M60.06%
Dec 31, 202215.22M14.10M1,258.57%
Dec 31, 20211.12M-13.46M-92.32%
Dec 31, 202014.58M13.83M1,846.60%
Dec 31, 2019749.00K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
NeueHealth 1.03B
FibroGen 173.82M
CareCloud 111.75M
Apyx Medical 49.03M
Qilian International Holding Group 29.87M
LAVA Therapeutics 7.40M
Revenue Rankings

AADI News

More News